免疫检查点抑制剂相关心肌炎的报告。 - Suppr

Suppr

超能文献

Reporting of immune checkpoint inhibitor-associated myocarditis.

作者信息

Al-Kindi Sadeer G, Oliveira Guilherme H

机构信息

Cardio-oncology Program, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.

出版信息

Lancet. 2018 Aug 4;392(10145):382-383. doi: 10.1016/S0140-6736(18)31542-3.

DOI:10.1016/S0140-6736(18)31542-3

PMID:30102167

Abstract

摘要

相似文献

Reporting of immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎的报告。

Lancet. 2018 Aug 4;392(10145):382-383. doi: 10.1016/S0140-6736(18)31542-3.

Reporting of immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎的报告

Lancet. 2018 Aug 4;392(10145):383. doi: 10.1016/S0140-6736(18)31549-6.

Reporting of immune checkpoint inhibitor-associated myocarditis.

Lancet. 2018 Aug 4;392(10145):383-384. doi: 10.1016/S0140-6736(18)31557-5.

Reporting of immune checkpoint inhibitor-associated myocarditis - Authors' reply.免疫检查点抑制剂相关心肌炎的报告——作者回复

Lancet. 2018 Aug 4;392(10145):384-385. doi: 10.1016/S0140-6736(18)31556-3.

Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab.伴有抗程序性死亡蛋白1（PD-1）抗体纳武单抗的急性淋巴细胞性心肌炎

Circ Heart Fail. 2016 Oct;9(10). doi: 10.1161/CIRCHEARTFAILURE.116.003514.

Myocarditis with Immune Checkpoint Blockade.免疫检查点阻断相关心肌炎

N Engl J Med. 2017 Jan 19;376(3):290-1. doi: 10.1056/NEJMc1615251.

Myocarditis with Immune Checkpoint Blockade.免疫检查点阻断相关心肌炎

N Engl J Med. 2017 Jan 19;376(3):291-292. doi: 10.1056/NEJMc1615251.

Myocarditis with Immune Checkpoint Blockade.免疫检查点阻断相关心肌炎

N Engl J Med. 2017 Jan 19;376(3):292. doi: 10.1056/NEJMc1615251.

Fatal Myocarditis Following Treatment with the PD-1 Inhibitor Nivolumab.使用PD-1抑制剂纳武单抗治疗后发生的致命性心肌炎。

J Forensic Sci. 2018 May;63(3):954-957. doi: 10.1111/1556-4029.13633. Epub 2017 Aug 17.

Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy.免疫检查点抑制剂治疗致危及生命的自身免疫性心肌病在患者中可重现。

J Immunother. 2018 Jan;41(1):35-38. doi: 10.1097/CJI.0000000000000190.

引用本文的文献

Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management.免疫检查点抑制剂相关心脏毒性的应对：从诊断到长期管理

J Cardiovasc Dev Dis. 2025 Jul 16;12(7):270. doi: 10.3390/jcdd12070270.

Preclinical mouse models of immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎的临床前小鼠模型

Nat Cardiovasc Res. 2025 May;4(5):526-538. doi: 10.1038/s44161-025-00640-2. Epub 2025 May 7.

Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.在 COVID-19 时代，接受免疫检查点抑制剂治疗的黑色素瘤患者的肌炎和可能的心炎增加。

Cancer Immunol Immunother. 2024 Oct 5;73(12):259. doi: 10.1007/s00262-024-03803-5.

Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab.案例报告：在与派姆单抗联合使用时，PD-L1 依赖性 CD28 共刺激剂和双重 PD-L1/CTLA-4 检查点抑制剂达沃西妥单抗（ALPN-202）治疗后发生致命性免疫介导性心肌炎。

J Immunother Cancer. 2024 Aug 13;12(8):e009475. doi: 10.1136/jitc-2024-009475.

Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.帕博利珠单抗致转移性膀胱癌患者心肌炎伴完全性房室传导阻滞和同时性肌炎：病例报告及文献复习。

J Med Case Rep. 2024 Feb 22;18(1):107. doi: 10.1186/s13256-024-04397-3.

Population-scale identification of differential adverse events before and during a pandemic.大流行之前和期间人群规模的差异性不良事件识别。

Nat Comput Sci. 2021 Oct;1(10):666-677. doi: 10.1038/s43588-021-00138-4. Epub 2021 Oct 5.

Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment.心肌炎最新进展：从病因、临床表现到现代诊断与治疗方法

Diagnostics (Basel). 2023 Sep 28;13(19):3073. doi: 10.3390/diagnostics13193073.

Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies.免疫检查点抑制剂相关心肌炎：当前认识和潜在的诊断及治疗策略。

Expert Opin Drug Saf. 2023 Jul-Dec;22(10):909-919. doi: 10.1080/14740338.2023.2254218. Epub 2023 Sep 4.

Treatment of Immune Checkpoint Inhibitor-associated Myocarditis.免疫检查点抑制剂相关性心肌炎的治疗。

J Cardiovasc Pharmacol. 2024 May 1;83(5):384-391. doi: 10.1097/FJC.0000000000001456.

Cardiovascular events after the initiation of immune checkpoint inhibitors.免疫检查点抑制剂开始使用后的心血管事件。

Heliyon. 2023 May 18;9(5):e16373. doi: 10.1016/j.heliyon.2023.e16373. eCollection 2023 May.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验